# HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer

> **NCT03111615** · PHASE4 · UNKNOWN · sponsor: **Centro Hospitalar Lisboa Ocidental** · enrollment: 90 (estimated)

## Conditions studied

- Hormone Dependent Neoplasms
- Breast Cancer Female

## Interventions

- **DRUG:** Aromatase Inhibitors

## Key facts

- **NCT ID:** NCT03111615
- **Lead sponsor:** Centro Hospitalar Lisboa Ocidental
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-01
- **Primary completion:** 2019-05-01
- **Final completion:** 2020-05-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2017-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03111615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03111615, "HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03111615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*